Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. 1986

H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan

We studied 17 patients with moderate to mild type I von Willebrand's disease (vWd) and correlated the bleeding time with the plasma von Willebrand factor antigen (vWf Ag), the plasma vWf activity (ristocetin cofactor), the platelet vWf Ag, and the platelet vWf activity. We found an excellent correlation between the bleeding time and the platelet vWf activity and, to a lesser extent, between the bleeding time and the platelet vWf Ag. The length of the bleeding time was inversely proportional to the level of the platelet vWf (P less than .001) or, to a lesser extent, the platelet vWf Ag (P less than .05). The plasma vWf Ag and activity did not correlate significantly with the bleeding time. These studies indicate that the platelet vWf is one of the important bleeding time factors in type I vWd and that the platelet vWf plays an important role in the early steps of hemostasis.

UI MeSH Term Description Entries
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias

Related Publications

H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
September 1985, Scandinavian journal of haematology,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
January 1987, Haemostasis,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
April 1985, Thrombosis and haemostasis,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
October 1990, Thrombosis and haemostasis,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
May 1985, Thrombosis research,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
December 1984, Thrombosis and haemostasis,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
January 1994, American journal of veterinary research,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
November 1975, British medical journal,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
April 1991, Harefuah,
H R Gralnick, and M E Rick, and L P McKeown, and S B Williams, and R I Parker, and P Maisonneuve, and C Jenneau, and Y Sultan
February 1988, European journal of haematology,
Copied contents to your clipboard!